This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Hapvida, Plamed under investigation in Brazil for failing to comply with structural remedies on deal

By Ana Paula Candil ( October 8, 2021, 18:23 GMT | Insight) -- Hapvida and Plamed are under scrutiny by the Brazilian competition authority for failing to comply with structural remedies imposed on them when their deal was approved in February. The parties asked the Administrative Council for Economic Defense, or CADE, for more time to find a buyer for Plamed's client portfolios of individual or family medical-hospital healthcare plans and of collective medical-hospital healthcare plans in Aracajú in Sergipe state. Hapvida and Plamed are under scrutiny by the Brazilian competition authority for failing to comply with structural remedies imposed on them when their deal was approved in February....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login